Arnaldo Damas-Parra
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Is phosphorylated tau a good biomarker of synapse pathology in Alzheimer's disease?
Journal: Brain communications
Published: April 11, 2023
Editorial: Bidirectional Communication Between Synapses and Nucleus in Brain Physiology and Disease.
Editorial: Bidirectional Communication Between Synapses and Nucleus in Brain Physiology and Disease.
Journal: Frontiers in molecular neuroscience
Published: March 31, 2022
Revealing cell vulnerability in Alzheimer's disease by single-cell transcriptomics.
Journal: Seminars in cell & developmental biology
Published: February 25, 2022
Tissue Clearing and Expansion Methods for Imaging Brain Pathology in Neurodegeneration: From Circuits to Synapses and Beyond.
Journal: Frontiers in neuroscience
Published: May 10, 2020
Synapse-to-Nucleus Signaling in Neurodegenerative and Neuropsychiatric Disorders.
Journal: Biological psychiatry
Published: November 06, 2018
Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice.
Journal: Scientific reports
Published: January 25, 2018
CRTC1 mediates preferential transcription at neuronal activity-regulated CRE/TATA promoters.
Journal: Scientific reports
Published: September 12, 2017
CRTC1 Function During Memory Encoding Is Disrupted in Neurodegeneration.
Journal: Biological psychiatry
Published: December 01, 2015
Gene expression parallels synaptic excitability and plasticity changes in Alzheimer's disease.
Journal: Frontiers in cellular neuroscience
Published: May 21, 2015
Crtc1 activates a transcriptional program deregulated at early Alzheimer's disease-related stages.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: April 25, 2014
Last Updated: 09/26/2026